The reactor with controlled feed rate and temperature allows rapid optimization of processing for your specific needs, and our engineering and sales team is always available to answer your questions.
Materials Research Centre (MRC) offers manufacturing of Etching Reactor for MXene synthesis.
MRC mission is technology development, design and manufacturing of specialized laboratory equipment for different research needs. Our staff includes engineers trained in design, manufacturing, as well as nanotechnology, chemistry, electrochemistry, and materials science. We can help you to develop solutions for your needs within a wide range of materials and equipment for their manufacturing.
ETCHING REACTOR FOR ACID ETCHING OF MAX-PHASE POWDERS, PRODUCTIVITY UP to 100 g / DAY
While most nanomaterials are only available in “nano” quantities, research team of professor Yury Gogotsi in Drexel Nanomaterials Institute, Drexel Universuty (USA) can make in their lab as much as 100 grams of MXene at a time, using a reactor developed with the Materials Research Center in Ukraine.
The reactor with controlled feed rate and temperature allows rapid optimization of processing for your specific needs, and our engineering and sales team is always available to answer your questions.
Operation of of Etching Reactor for MXene synthesis
Solution for MAX-phase for etching is poured into reactor and hermetically closed by a cover, which enables a controlled and safe removal of hydrogen.
MAX-phase feeding is done at a constant rate. To prevent deposition of material, the solution is constantly mixed. Chemical reaction of MAX-phase etching is exothermic. A water-cooled shell and feeder for material supply are designed for the temperature control.
MAX-phase etching is done following, for example, the reaction:
Ti3AlC2 + 3HF + 2H2O = AlF3 + 5/2H2 + Ti3C2(ОН)2
Hydrogen that is formed during the etching process flows into the discharge system for further utilization or is discharged. After etching, the solution is discharged for product purification from reaction products and other impurities.
MRC offers:
Technology development
Flexible engineering design
Customized manufacturing tailored to meet your needs
MRC encourage you to learn more about the exciting possibilities we can offer you, and we look forward to partnering with you to improve your material's synthesis and manufacturing.
For further information and detailes about ordering MAX-phase powders and Etching Reactor for MXene synthesis please contact us at Этот e-mail адрес защищен от спам-ботов, для его просмотра у Вас должен быть включен Javascript
MXenes potential applications include sensors, wound healing materials, and drug delivery systems. A recent study explored how different synthesis methods affect the safety and performance of MXenes. By comparing etching conditions and intercalation strategies, researchers discovered that fine-tuning the surface chemistry of MXenes plays a crucial role in improving biocompatibility. These results provide practical guidelines for developing safer MXenes and bring the field one step closer to real biomedical applications.
Exellent news, our joint patent application with Drexel University on highly porous MAX phase precursor for MXene synthesis published. Congratulations and thanks to all team involved!
Last Call! Have you submitted your abstract for IEEE NAP-2025 yet? Join us at the International Symposium on "The MXene Frontier: Transformative Nanomaterials Shaping the Future" – the largest MXene-focused conference in Europe this year! Final Submission Deadline: May 15, 2025. Don’t miss this exclusive opportunity to showcase your research and engage with world leaders in the MXene field!
We are excited to announce the publication of latest review article on MXenes in Healthcare. This comprehensive review explores the groundbreaking role of MXenes—an emerging class of 2D materials—in revolutionizing the fields of medical diagnostics and therapeutics. Read the full article here: https://doi.org/10.1039/D4NR04853A.
Congratulations and thank you to our collaborators from TU Wien and CEST for very interesting work and making it published! In this work, an upscalable electrochemical MXene synthesis is presented. Yields of up to 60% electrochemical MXene (EC-MXene) with no byproducts from a single exfoliation cycle are achieved.
Congratulations to all collaborators with this interesting joint work!
Thank you to our collaborators for the amazing joint work recently published in Graphene and 2D Nanomaterials about MXene–silk fibroin composite films aiming to develop materials with tunable electronic and thermal properties
Dr. Oleksiy Gogotsi, director of MRC and Carbon-Ukraine, innovative companies that are among the leaders on the world MXene market, visited 2024 MRS Fall Meeting & Exhibit. together with Dr. Maksym Pogorielov, Head of Advanced Biomaterials and Biophysics Laboratory, University of Latvia.
MRC and Carbon-Ukraine team visited the 3rd International MXene conference held at Drexel University on August 5-8, 2024. Conference brought together the best reserchers and leading experts on MXene field. 
Together with colleagues from the University of Latvia, MRC/Carbone Ukraine, Adam Mickiewicz University, University Clinic Essen, and others, we have developed a novel concept involving the binding of antibodies to MXenes. In our research, we utilized anti-CEACAM1 antibodies to develop targeted photo-thermal therapy for melanoma (in vitro), paving the way for future in vivo studies and clinical trials. For the first time, we demonstrate the feasibility of delivering MXenes specifically targeted to melanoma cells, enabling the effective ablation of cancer cells under near-infrared (NIR) light. This new technique opens up vast potential for the application of MXenes in cancer treatment, diagnostics, drug delivery, and many other medical purposes.
